Exploring the Possible Mechanism of Combination of Polygonati rhizoma and Angelicae sinensis in Preventing Alzheimer’s Disease
College of Biological & Environmental Sciences, Zhejiang Wanli University, Ningbo 315100, China
| Abstract: | Alzheimer's disease (AD) is a neurodegenerative disorder, mainly manifested by cognitive and behavioral impairments, a serious threat to life, and without specific therapeutic drugs. The combination of Polygonati rhizoma and Angelicae sinensis (CPA) conforms to the principle of Chinese medicine formulation and has good effect on the prevention and treatment of AD, but there is a lack of discussion on its target effect and clinical mechanism. In this study, the core targets and key pathways between CPA and AD were analyzed by network pharmacology and molecular docking methods. The results showed that active compounds in CPA (such as baicalin, glycyrrhizin, stigmasterol, diosgenin, cis-ligustilide, etc.) played anti-inflammatory and anti-apoptotic effects by regulating key targets (such as APP, EGFR, ESR1, PTGS2, etc.) in related signaling pathways (such as Alzheimer's disease pathway, NF-kB signaling pathways, etc. ) to reduce the aggregation of β amyloid protein and inhibit Tau hyperphosphorylation, and the core components of CPA had good molecular docking activity with the core targets of the pathway. These results indicated that CPA played a role in preventing and improving Alzheimer's disease by regulating multi-target and multi-channel. These results will provide effective treatment basis for future clinical research. |
| Keywords: | Combination of Polygonati rhizoma and Angelicae sinensis (CPA); Alzheimer’s Disease (AD); Network Pharmacology; Baicalein; APP; Alzheimer Disease Pathway |
| DOI: | 10.57237/j.cmrd.2024.02.002 |
View:
Downloads:
Received: 29 July 2024
Accepted: 6 September 2024
Published Online: 9 September 2024
References
| [1] | Ko YH, Kwon SH, Lee SY, et al. Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus. Arch Pharm Res 2017; 40(10): 1209-1217; https://doi.org/10.1007/s12272-017-0954-6 |
| [2] | Gauthier S, Webster C, Servaes S, et al. World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. London, England: Alzheimer’s Disease International. 2022. |
| [3] | Jiang RQ, Zhao ZG. Selection and advancement of pharmacotherapies for dementia. Clinical Medication Journal 2022; 20(01): 30-36. https://doi.org/10.3969/j.issn.1672-3384 |
| [4] | Ferreira, Ana, Márcio Rodrigues, Ana Fortuna, et al. Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology. Phytochemistry Reviews 2014; 15(1): 51-85; https://doi.org/10.1007/s11101-014-9384-y |
| [5] | Zhang C. Investigation of memantine long-acting injections. Jiangnan University, 2021. https://doi.org/10.27169/d.cnki.gwqgu.2021.001719 |
| [6] | Nikvarz N, Alaghband-Rad J, Tehrani-Doost M, et al. Comparing efficacy and side effects of memantine vs. risperidone in the treatment of autistic disorder. Pharmacopsychiatry 2017; 50(1): 19–25; https://doi.org/10.1055/s-0042-108449 |
| [7] | Chandra S, Jana M, Pahan K. Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer’s disease via PPARα. J Neurosci 2018; 38(30): 6682-6699; https://doi.org/10.1523/JNEUROSCI.0054-18 |
| [8] | Yokoyama S, Yoshinaga T, Matsuzaki J, et al. A randomized, double-blind, placebo-controlled study to evaluate the efficacy of teprenone in patients with Alzheimer′s disease. J Alzheimer’s Dis 2019; 71(4): 1187-1199; https://doi.org/10.3233/JAD-190305 |
| [9] | Zhu YM, Li MQ, Guan SW, et al. Effects of “Jiedu Yizhi” formula on neuroprotection and Aβ peptide aggregation in transgenic nematodes with Alzheimer's disease. Chinese Journal of Gerontology 2018; 38(23): 5789-5791; https://doi.org/10.3969/j.issn.1005-9202 |
| [10] | Md Sahab Uddin, Md Tanvir Kabir. Emerging signal regulating potential of genistein against Alzheimer′s disease: A promising molecule of interest. Front Cell Dev Biol 2019; 7: 197-209; https://doi.org/10.3389/fcell.2019.00197 |
| [11] | Li B, Tai Y, Chi ZS, et al. Effect of resveratrol on apoptosis of cerebral nerve cells in AD rats based on endoplasmic reticulum stress PERK-ATF4-CHOP signaling pathway. Chinese Journal of Immunology 2020; 36(20): 2443-2446; https://doi.org/10.3969/j.issn.1000-484X |
| [12] | Zhou Y, Chen S, Qiao J, et al. Study of the noncovalent interactions of ginsenosides and amyloid-beta-peptide by CSI-MS and molecular docking.J Mass Spectrom 2020; 55(1): e4463; https://doi.org/10.1002/jms.4463 |
| [13] | Yao XJ, Deng ZY, Li HY, et al. Effect of processing cycles on the composition of Polygonatum cyrtonema Hua during nine-steam-nine-bask processing. Food Bioscience 2022; 50: p102081; https://doi.org/10.1016/J.FBIO.2022.102081 |
| [14] | Huang LP, Yang XY, Yan B, et al. Effect of Erjingwan on hippocampal proteomics in AD rats with kidney yin deficiency induced by ovariectomy + D-galactose combind with Aβ1-40. Chinese Journal of Experimental Traditional Medical Formulae 2020; 26(09): 15-22; https://doi.org/10.13422/j.cnki.syfjx.20200637 |
| [15] | Xiao YS, Zeng YF, Xu YJ, et al. The experimental study of the treatment effects of Rhizoma Polygonati and Earth Worm mixtures on Alzheimer’s disease in mice. Pharmacology and Clinics of Chinese Materia Medica 2013; 29(02): 152-154; https://doi.org/10.13412/j.cnki.zyyl.2013.02.055 |
| [16] | Wang HP, Wu HY, Li HL, et al. Experimental study on the optimization of the combination of effective components of Angelica sinensis in the prevention and treatment of Alzheimer's disease in rat models. Journal of Gansu University of Chinese Medicine 2019; 36(03): 12-19; https://doi.org/10.16841/j.issn1003-8450.2019.03.03 |
| [17] | Yang JY, Xiao YS, Jiang JL, et al. Effect of huangjing pill on antioxidant function and Aβ1-40 and APP protein expressions in brain of Alzheimer’s disease rats. Chinese Journal of Experimental Traditional Medical Formulae, 2020, 26(06): 32-38; https://doi.org/10.13422/j.cnki.syfjx.20200305 |
| [18] | Qian JY. The research on the mechanism of Huangjing and Danggui drug pair promoting hippocampal stem cells proliferation in mice with AD by Wnt/β-catenin signaling pathway. Jiangxi University of Traditional Chinese Medicine, 2022; https://doi.org/: 10.27180/d.cnki.gjxzc.2022.000411 |
| [19] | Yang JY, Xiao YS, Xiao AJ, et al. Feasibility analysis and study progress of effect of huangjingwan in prevention and treatment of Alzheimer's disease. Chinese Journal of Experimental Traditional Medical Formulae 2021; 27(01): 46-52; https://doi.org/10.13422/j.cnki.syfjx.20202105 |
| [20] | Zheng Q, Wang X, Gao T, et al. Exploring the pharmacological and molecular mechanisms of Salvia chinensis Benth in colorectal cancer: A network pharmacology and molecular docking study. Medicine 2023; 102(50): p e36602; https://doi.org/10.1097/MD.0000000000036602 |
| [21] | Ren HM, Deng YL, Zhang JL, et al. Research progress on processing history evolution, chemical components and pharmacological effects of Polygonati Rhizoma. China Journal of Chinese Materia Medica 2020, 45(17): 4163-4182; https://doi.org/ 10.19540/j.cnki.cjcmm.20200522.601 |
| [22] | Li X, Zhang LH, Wang XX, et al. Research progress on chemical components and pharmacological effects of Angelica sinensis. Journal of Chinese Medicinal Materials 2013; 36(06): 1023-1028; https://doi.org/10.13863/j.issn1001-4454.2013.06.049 |
| [23] | Chen YY, Kong LH, Sun GJ, et al. The Study about the impact of “supplementing kidney and strengthening du meridian" acupuncture and moxibustion method on AD rats’ a beta level and its precursor protein APP. Lishizhen Medicine and Materia Medica Research 2016; 27(09): 2289-2291; https://doi.org/10.3969/j.issn.1008-0805 |
| [24] | Li Q, Chen M, Liu H, et al. Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment. Mol Med Rep 2012; 6(6): 1450-1454; https://doi.org/10.3892/mmr.2012.1102 |
| [25] | Man J, Cui K, Fu X, et al. Donepezil promotes neurogenesis via Src signaling pathway in a rat model of chronic cerebral hypoperfusion. Brain Res 2020; 1736: 146782; https://doi.org/10.1016/j.brainres.2020.146782 |
| [26] | Scacchi R, Gambina G, Broggio E, et al. Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2014; 29(6): 610-615; https://doi.org/10.1002/gps.4043 |
| [27] | Arikawa M, Kakinuma Y, Handa T, et al. Donepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice. PLoS One 2011; 6(7): e20629; https://doi.org/10.1371/journal.pone.0020629 |
| [28] | Lu Q, Zou LF, Gao YZ, et al. The protective effect and mechanism of liquiritigenin on UVA-induced photoaging. Chinese Journal of New Drugs 2022; 31(20): 2056-2066; https://doi.org/10.3969/j.issn.1003-3734.2022.20.015 |
| [29] | Liu RT, Zou LB, Lü QJ. Liquiritigenin inhibits Abeta (25-35)-induced neurotoxicity and secretion of Abeta (1-40) in rat hippocampal neurons. Acta Pharmacol Sin 2009; 30(7): 899-906; https://doi.org/ 10.1038/aps.2009.74 |
| [30] | Chen J, Yang L, Zuo YJ, et al. Effect of baicalin on cognitive impairment in rats with chronic cerebral hypoperfusion and its mechanism. Central South Pharmacy 2021; 19(7): 1333-1338; https://doi.org/10.7539/j.issn.1672-2981 |
| [31] | Xie T, Pei Y, Shan P, et al. Identification of miRNA–mRNA pairs in the Alzheimer’s disease expression profile and explore the effect of miR-26a-5p/PTGS2 on amyloid-β induced neurotoxicity in Alzheimer’s disease cell model. Frontiers in Aging Neuroscience 2022; 14: 909222; https://doi.org/10.3389/FNAGI.2022.909222 |
| [32] | Sánchez-Crisóstomo I, Fernández-Martínez E, Cariño-Cortés R, et al. Phytosterols and triterpenoids for prevention and treatment of metabolic-related liver diseases and hepatocellular carcinoma. Curr Pharm Biotechnol 2019; 20(3): 197-214; https://doi.org/10.2174/1389201020666190219122357 |
| [33] | Huse JT, Pijak DS, Leslie GJ, et al. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J Biol Chem 2000; 275(43): 33729-33737; https://doi.org/10.1074/jbc.M004175200 |
| [34] | Jie F, Yang X, Wu L, et al. Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms. Crit Rev Food Sci Nutr 2021; 62(13): 11-18; https://doi.org/10.1080/10408398.2020.1867819 |
| [35] | Ra JJ, Rao C. Diosgenin, a steroid saponin constituent of yams and fenugreek: emerging evidence for applications in medicine. Bioactive Compounds in Phytomedicine.2012. https://doi.org/10.5772/26700 |
| [36] | Tohda C, Urano T, Umezaki M, et al. Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Sci Rep 2012; 2(1): 535-546; https://doi.org/10.1038/srep00535 |
| [37] | Li BY, Xu PL, Wu SY, et al. Diosgenin attenuates lipopolysaccharide-induced Parkinson’s disease by inhibiting the TLR/NF-kB pathway. Journal of Alzheimer's Disease 2018; 64: 943-955; https://doi.org/10.3233/JAD-180330 |
| [38] | Wu Q, Wang N, Liu J, et al. Effect of ligustilide on oxygen and glucose deprivation/reperfusion-induced mitochondria fission in PC12 cells. China Journal of Chinese Materia Medica 2020; 45(16): 3931-3937; https://doi.org/10.19540/j.cnki.cjcmm.20200316.401 |
| [39] | Wang YC, Huang Y, Wang Y, et al. Protection of Z-ligustilide on human umbilical vein endothelial cells and its mechanism. Chinese Traditional and Herbal Drugs 2013; 44(09): 1157-1161; https://doi.org/10.7501/j.issn.0253-2670 |
| [40] | Huang J, Wang X, Xie L, et al. Extract of Danggui-Shaoyao-San ameliorates cognition deficits by regulating DHA metabolism in APP/PS1 mice. J Ethnopharmacol 2020; 253: 112673; https://doi.org/10.1016/j.jep.2020.112673 |
| [41] | Rawat C, Kutum R, Kukal S, et al. Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy. Sci. Rep 2020; 10(1): 2546-2560; https://doi.org/ 10.1038/s41598-020-59259-x |
| [42] | Zhou Z, Zheng L, Qi L, et al. Silencing of PTGS2 exerts promoting effects on angiogenesis endothelial progenitor cells in mice with ischemic stroke via repression of the NF-kB signaling pathway. J Cell Physiol 2019; 234(12): 23448-23460; https://doi.org/10.1002/jcp.28914 |
| [43] | Prabhakaran J, Molotkov A, Mintz A, et al. Progress in PET imaging of neuroinflammation targeting COX-2 enzyme. Molecules 2021; 26(11): 3208-3208; https://doi.org/10.3390/MOLECULES26113208 |
| [44] | Kunzler J, Youmans KL, Yu C, et al. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice. Neurosci Lett 2014; 560: 131-136; https://doi.org/10.1016/j.neulet.2013.12.032 |
| [45] | Broome R, Chernukhin I, Jamieson S, et al. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell Rep 2021; 34: 108776; https://doi.org/10.1016/J.CELREP.2021.108776 |
| [46] | Pereira CD, Martins F, Wiltfang J, et al. ABC transporters are key players in Alzheimer's disease. J Alzheimers Dis 2018; 61(2): 463-485; https://doi.org/10.3233/JAD-170639 |
| [47] | Gratuze M, Joly-Amado A, Vieau D, et al. Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies? Neuroendocrinology 2018; 107(2): 181-195; https://doi.org/10.1159/000487641 |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us